Ethico-legal points to consider for future international research collaborations to study other diseases

Generalized guidance to assist future data-driven cancer and medical research initiatives, on topics such as when genomic analysis may be considered a medical device, and thus subject to additional regulatory requirements, and on the difference between anonymization and pseudonymization and its application to concrete circumstances such as the sharing of somatic or germline variants.